147 related articles for article (PubMed ID: 24784755)
1. Prolonged use of nimotuzumab in children with central nervous system tumors: safety and feasibility.
Cabanas R; Saurez G; Alert J; Reyes A; Valdes J; Gonzalez MC; Pedrayes JL; Valle L; Infante M; Avila M; Herrera R; Hechavarria E; Rios M; Fernández A; Lorenzo Luaces P; Crombet Ramos T
Cancer Biother Radiopharm; 2014 May; 29(4):173-8. PubMed ID: 24784755
[TBL] [Abstract][Full Text] [Related]
2. Nimotuzumab therapy in the treatment of pediatric central nervous system tumors: single-center experience.
Susam-Sen H; Varan A; Bajin İ; Göçmen R; Aydın B; Yalcin B; Kurucu N; Kutluk T; Bayhan T; Akyuz C
Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1769-1777. PubMed ID: 34151393
[TBL] [Abstract][Full Text] [Related]
3. Treatment of children with high grade glioma with nimotuzumab: a 5-year institutional experience.
Cabanas R; Saurez G; Rios M; Alert J; Reyes A; Valdes J; Gonzalez MC; Pedrayes JL; Avila M; Herrera R; Infante M; Echevarria E; Moreno M; Luaces PL; Ramos TC
MAbs; 2013; 5(2):202-7. PubMed ID: 23575267
[TBL] [Abstract][Full Text] [Related]
4. [Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
Yang QY; Shen D; Sai K; Mu YG; Jiang XB; Zhang XH; Chen ZP
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):232-5. PubMed ID: 21575527
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial.
Solomón MT; Selva JC; Figueredo J; Vaquer J; Toledo C; Quintanal N; Salva S; Domíngez R; Alert J; Marinello JJ; Catalá M; Griego MG; Martell JA; Luaces PL; Ballesteros J; de-Castro N; Bach F; Crombet T
BMC Cancer; 2013 Jun; 13():299. PubMed ID: 23782513
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
Fouladi M; Nicholson HS; Zhou T; Laningham F; Helton KJ; Holmes E; Cohen K; Speights RA; Wright J; Pollack IF;
Cancer; 2007 Dec; 110(11):2535-41. PubMed ID: 17932894
[TBL] [Abstract][Full Text] [Related]
7. Reported outcomes of children with newly diagnosed high-grade gliomas treated with nimotuzumab and irinotecan.
Sirachainan N; Boongird A; Swangsilpa T; Klaisuban W; Lusawat A; Hongeng S
Childs Nerv Syst; 2017 Jun; 33(6):893-897. PubMed ID: 28439659
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and tolerability of bevacizumab in children with primary CNS tumors.
Reismüller B; Azizi AA; Peyrl A; Heinrich M; Gruber-Olipitz M; Luckner D; Rothschild KV; Slavc I
Pediatr Blood Cancer; 2010 May; 54(5):681-6. PubMed ID: 20066713
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends.
Couec ML; André N; Thebaud E; Minckes O; Rialland X; Corradini N; Aerts I; Marec Bérard P; Bourdeaut F; Leblond P;
Pediatr Blood Cancer; 2012 Jul; 59(1):34-8. PubMed ID: 22287258
[TBL] [Abstract][Full Text] [Related]
10. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
[TBL] [Abstract][Full Text] [Related]
11. Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.
Fleischhack G; Massimino M; Warmuth-Metz M; Khuhlaeva E; Janssen G; Graf N; Rutkowski S; Beilken A; Schmid I; Biassoni V; Gorelishev SK; Kramm C; Reinhard H; Schlegel PG; Kortmann RD; Reuter D; Bach F; Iznaga-Escobar NE; Bode U
J Neurooncol; 2019 May; 143(1):107-113. PubMed ID: 30830679
[TBL] [Abstract][Full Text] [Related]
12. A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors.
Okamoto W; Yoshino T; Takahashi T; Okamoto I; Ueda S; Tsuya A; Boku N; Nishio K; Fukuoka M; Yamamoto N; Nakagawa K
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1063-71. PubMed ID: 24046058
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with nimotuzumab in cuban pediatric patients with brain tumors, 2005 to 2007.
Saurez G; Cabanas R; Zaldívar M; Garnier T; Iglesias B; Piedra P; Castillo MR; Longchong M; Iznaga N; Lage A
MEDICC Rev; 2009 Jul; 11(3):27-33. PubMed ID: 21483304
[TBL] [Abstract][Full Text] [Related]
14. Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience.
Solomon MT; Miranda N; Jorrín E; Chon I; Marinello JJ; Alert J; Lorenzo-Luaces P; Crombet T
Cancer Biol Ther; 2014 May; 15(5):504-9. PubMed ID: 24521695
[TBL] [Abstract][Full Text] [Related]
15. Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.
Bartels U; Wolff J; Gore L; Dunkel I; Gilheeney S; Allen J; Goldman S; Yalon M; Packer RJ; Korones DN; Smith A; Cohen K; Kuttesch J; Strother D; Baruchel S; Gammon J; Kowalski M; Bouffet E
Neuro Oncol; 2014 Nov; 16(11):1554-9. PubMed ID: 24847085
[TBL] [Abstract][Full Text] [Related]
16. Nimotuzumab in pediatric glioma.
Lam C; Bouffet E; Bartels U
Future Oncol; 2009 Nov; 5(9):1349-61. PubMed ID: 19903064
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.
Cetina L; Crombet T; Jiménez-Lima R; Zapata S; Ramos M; Avila S; Coronel J; Charco E; Bojalil R; Astudillo H; Bazán B; Dueñas-González A
Cancer Biol Ther; 2015; 16(5):684-9. PubMed ID: 25802932
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
19. Profile of nimotuzumab in the treatment of high-grade glioma.
Yang QY; Guo CC; Chen ZP
Onco Targets Ther; 2015; 8():819-25. PubMed ID: 25926743
[TBL] [Abstract][Full Text] [Related]
20. Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
Gerber NU; von Hoff K; Resch A; Ottensmeier H; Kwiecien R; Faldum A; Matuschek C; Hornung D; Bremer M; Benesch M; Pietsch T; Warmuth-Metz M; Kuehl J; Rutkowski S; Kortmann RD
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):863-71. PubMed ID: 24969797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
